Business Description
Core Laboratories Inc
NAICS : 213112
SIC : 3533
ISIN : NL0000200384
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 4 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.19 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.7 | |||||
3-Year EPS without NRI Growth Rate | 166.1 | |||||
3-Year FCF Growth Rate | -33.6 | |||||
3-Year Book Growth Rate | 44.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.58 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.98 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 1.79 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 59.76 | |||||
Days Sales Outstanding | 78.43 | |||||
Days Payable | 28.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -47.7 | |||||
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 3.62 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 17.56 | |||||
Operating Margin % | 10.22 | |||||
Net Margin % | 5.01 | |||||
FCF Margin % | 8.42 | |||||
ROE % | 11.17 | |||||
ROA % | 4.42 | |||||
ROIC % | 6.22 | |||||
ROC (Joel Greenblatt) % | 21.72 | |||||
ROCE % | 11.72 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.67 | |||||
Forward PE Ratio | 21.69 | |||||
PE Ratio without NRI | 23.85 | |||||
Shiller PE Ratio | 11.62 | |||||
Price-to-Owner-Earnings | 19.03 | |||||
PS Ratio | 1.54 | |||||
PB Ratio | 3.15 | |||||
Price-to-Tangible-Book | 5.45 | |||||
Price-to-Free-Cash-Flow | 18.24 | |||||
Price-to-Operating-Cash-Flow | 14.54 | |||||
EV-to-EBIT | 16.46 | |||||
EV-to-EBITDA | 13.09 | |||||
EV-to-Revenue | 1.86 | |||||
EV-to-FCF | 22.06 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | 6.08 | |||||
FCF Yield % | 5.56 | |||||
Forward Rate of Return (Yacktman) % | 0.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Core Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 479.233 | ||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 0.07 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 23.8 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 23.8 - 23.8 | ||
Shares Outstanding (Mil) | 46.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Core Laboratories Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Core Laboratories Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Core Laboratories Inc Frequently Asked Questions
What is Core Laboratories Inc(LTS:0Q82)'s stock price today?
When is next earnings date of Core Laboratories Inc(LTS:0Q82)?
Does Core Laboratories Inc(LTS:0Q82) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |